Literatur und wissenschaftliche Studien
Allgemein
Bhatty, R.S. (1986) Physiochemical and functional breadmaking properties of hull-les barley fractions, Cereal Chemistry 63 (1) 31
Borneo R, Leon AE (2012) Whole grain cereals: functional components and health benefits. Food Funct 3:110-119
Charalampopoulos D, Wang R, Pandiella SS, Webb C (2002) Application of cereals and cereal components in functional foods: a review. Int J Food Microbiol 79:131-141
Deutsche Gesellschaft für Ernährung (DGE) e.V. (2013) Ballaststoffe neu betrachtet. DGEinfo 08: 114–118
Deutsche Gesellschaft für Ernährung (DGE) e.V. (2011) Evidenzbasierte Leitlinie: Kohlenhydratzufuhr und Prävention ausgewählter ernährungsmitbedingter Krankheiten. Bonn: DGE
Dieckmann Cereals GmbH (2016) Der BetaLeben-Plan nach Dr. Behrens – Besser leben mit Beta Glucan aus Gerste
Dieckmann, K. (2015) Gerste erhält wieder mehr Aufmerksamkeit – Was ist das Besondere?, VFED aktuell 148: 7–11
Schulze-Lohmann, P. (2012) Ballaststoffe. Grundlagen – präventives Potenzial – Empfehlungen für die Lebensmittelauswahl. Ernährungs Umschau; 7: 407–408
Blutzucker
Chen J, Raymond K (2008) Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag 4:1265-1272
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS (2014) Nutrition Therapy Recommendations for the Management of Adults With Diabetes. Diabetes Care 37:S120-S143
Hinata M, Ono M, Midorikawa S, Nakanishi K (2007) Metabolic improvement of male prisoners with type 2 diabetes in Fukushima Prison, Japan. Diabetes Res Clin Pract 77:327-332
Hou QT, Li Y, Li L, Cheng GP, Sun X, Li SY, Tian HM (2015) The Metabolic Effects of Oats Intake in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Nutrients 7:10369-10387
Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products; European Journal of Clinical Nutrition (2013) 67, 310–317
Schlörmann, W., Glei, M. (2016) Beta-Glucan aus Getreide – Naturstoff mit Potential zur Prävention und Behandlung des Typ-2-Diabetes; Spitzenforschung Diabetologie
Tosh SM (2013) Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products. Eur J Clin Nutr 67:310-317
WHO. 10 facts about diabetes. http://www.who.int/features/factfiles/diabetes/en/ . 1-11-2014. 5-1-2016
Cholesterin senken
AbuMweis SS, Jew S, Ames NP (2010) beta-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials. Eur J Clin Nutr 64:1472-1480
Andersson M, Ellegard L, Andersson H (2002) Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am J Clin Nutr 76:1111-1116
EFSA Panel on Dietetic Products NaAN (2011) Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and „digestive function“ (ID 850) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 9:2207.-[21 pp.]
Ellegard L, Andersson H (2007) Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur J Clin Nutr 61:938-945
European Journal of Clinical Nutrition (abstract), 14-6-2016.
Darmgesundheit
den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325-2340
Hughes SA, Shewry PR, Gibson GR, McCleary BV, Rastall RA (2008) In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota. FEMS Microbiol Ecol 64:482-493
Mitsou EK, Panopoulou N, Turunen K, Spiliotis V, Kyriacou A (2010) Prebiotic potential of barley derived beta-glucan at low intake levels: A randomised, double-blinded, placebo-controlled clinical study. Food Research International 43:1086-1092
Schwiertz, A. (2013): Morbus-Crohn: Die Rolle der Darmbakterien. UGB-Forum spezial Ernährungstherapie: 40–42
Übergewicht
Interdisziplinäre Leitlinie der Qualität S3 zur Prävention und Therapie der Adipositas (2013) DAG, DDG, DGE, DGEM
